Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro

Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic drugs that would improve patients outcomes seems...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Magdalena Szaryńska, Agata Olejniczak-Kęder, Adrian Zubrzycki, Anna Wardowska, Zbigniew Kmieć
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
T
Acceso en línea:https://doaj.org/article/f238bb1d04a6494ca9f44fcad3067636
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f238bb1d04a6494ca9f44fcad3067636
record_format dspace
spelling oai:doaj.org-article:f238bb1d04a6494ca9f44fcad30676362021-11-11T15:05:36ZAspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro10.3390/app1121100092076-3417https://doaj.org/article/f238bb1d04a6494ca9f44fcad30676362021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/21/10009https://doaj.org/toc/2076-3417Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic drugs that would improve patients outcomes seems to be the right solution. Aspirin (ASA) is one of such eminent drugs. Our study demonstrated that ASA may exert synergistic effect with the anti-Fas antibody on CSCs of colorectal cancer cell lines. We found that such compound treatment inhibited the pro-cancerous effect of anti-Fas stimulation and decreased spherogenicity, survival and CD133-positive cells’ count. Additionally, ASA with anti-Fas antibody may have a positive impact on dendritic cells’ functions. Our innovative study explored simultaneous usage of two biologically active compounds which haven’t been considered in such combination to assess their significance in colorectal cancer cell biology.Magdalena SzaryńskaAgata Olejniczak-KęderAdrian ZubrzyckiAnna WardowskaZbigniew KmiećMDPI AGarticlecancer stem cellscolorectal canceranti-Fasaspirindendritic cellsTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 10009, p 10009 (2021)
institution DOAJ
collection DOAJ
language EN
topic cancer stem cells
colorectal cancer
anti-Fas
aspirin
dendritic cells
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
spellingShingle cancer stem cells
colorectal cancer
anti-Fas
aspirin
dendritic cells
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
Magdalena Szaryńska
Agata Olejniczak-Kęder
Adrian Zubrzycki
Anna Wardowska
Zbigniew Kmieć
Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro
description Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic drugs that would improve patients outcomes seems to be the right solution. Aspirin (ASA) is one of such eminent drugs. Our study demonstrated that ASA may exert synergistic effect with the anti-Fas antibody on CSCs of colorectal cancer cell lines. We found that such compound treatment inhibited the pro-cancerous effect of anti-Fas stimulation and decreased spherogenicity, survival and CD133-positive cells’ count. Additionally, ASA with anti-Fas antibody may have a positive impact on dendritic cells’ functions. Our innovative study explored simultaneous usage of two biologically active compounds which haven’t been considered in such combination to assess their significance in colorectal cancer cell biology.
format article
author Magdalena Szaryńska
Agata Olejniczak-Kęder
Adrian Zubrzycki
Anna Wardowska
Zbigniew Kmieć
author_facet Magdalena Szaryńska
Agata Olejniczak-Kęder
Adrian Zubrzycki
Anna Wardowska
Zbigniew Kmieć
author_sort Magdalena Szaryńska
title Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro
title_short Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro
title_full Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro
title_fullStr Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro
title_full_unstemmed Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro
title_sort aspirin exerts synergistic effect with anti-fas stimulation against colorectal cancer stem cells in vitro
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/f238bb1d04a6494ca9f44fcad3067636
work_keys_str_mv AT magdalenaszarynska aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro
AT agataolejniczakkeder aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro
AT adrianzubrzycki aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro
AT annawardowska aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro
AT zbigniewkmiec aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro
_version_ 1718437187813376000